Flagship results paper from the MedSeq Project published in Annals of Internal Medicine

Genomes2People |
June 2017

A remarkable 22% of patients had new monogenic disease risks, previously unknown to them or higher than expected. instead of showing signs of nervousness and upset, the patients took the next step into seeing a physician to discuss what they could do about it.